Specialty Eye Hospital Svjetlost, School of Medicine University of Rijeka, Zagreb, Croatia.
SCHWIND eye-tech-solutions, Kleinostheim, Germany.
Eye (Lond). 2023 Dec;37(18):3768-3775. doi: 10.1038/s41433-023-02601-0. Epub 2023 Jun 5.
To evaluate vision 3 months after SmartSight lenticule extraction treatments.
Case series.
This case series of patients were treated at Specialty Eye Hospital Svjetlost in Zagreb, Croatia. Sixty eyes of 31 patients consecutively treated with SmartSight lenticule extraction were assessed. The mean age of the patients was 33 ± 6 years (range 23-45 years) at the time of treatment with a mean spherical equivalent refraction of -5.10 ± 1.35 D and mean astigmatism of 0.46 ± 0.36 D. Monocular corrected distance visual acuity (CDVA), uncorrected distance visual acuity (UDVA) were assessed pre- and post-operatively. Ocular and corneal wavefront aberrations have been postoperatively compared to the preoperative baseline values. Changes in ocular wavefront refraction, as well as changes in keratometric readings are reported.
At 3 months post-operatively, mean UDVA was 20/20 ± 2. Spherical equivalent showed a low myopic residual refraction of -0.37 ± 0.58 D with refractive astigmatism of 0.46 ± 0.26 D postoperatively. There was a slight improvement of 0.1 Snellen lines at 3-months follow-up. Compared to the preoperative status, ocular aberrations (at 6 mm diameter) did not change at 3 months follow-up; whereas corneal aberrations increased (+0.22 ± 0.21 µm for coma; +0.17 ± 0.19 µm for spherical aberration; and +0.32 ± 0.26 µm for HOA-RMS). The same correction was determined using changes in ocular wavefront refraction, as well as changes in keratometric readings.
Lenticule extraction after SmartSight is safe and efficacious in the first 3 months postoperatively. The post-operative outcomes indicate improvements in vision.
评估 SmartSight 角膜透镜取出治疗后 3 个月的视力。
病例系列。
该病例系列研究对象在克罗地亚萨格勒布的 Svjetlost 眼科专科医院接受治疗。对 31 例连续接受 SmartSight 角膜透镜取出治疗的 60 只眼进行评估。患者的平均年龄为 33±6 岁(23-45 岁),治疗时的平均等效球镜度为-5.10±1.35D,平均散光为 0.46±0.36D。术前和术后分别评估单眼矫正远视力(CDVA)和未矫正远视力(UDVA)。术后比较眼和角膜波前像差与术前基线值。报告眼屈光折射变化和角膜曲率读数变化。
术后 3 个月,平均 UDVA 为 20/20±2。等效球镜显示低度近视残留折射-0.37±0.58D,术后屈光性散光 0.46±0.26D。术后 3 个月随访时,视力提高了 0.1 行。与术前相比,3 个月随访时眼像差(6mm 直径)没有变化;而角膜像差增加(彗差增加+0.22±0.21μm;球差增加+0.17±0.19μm;HOA-RMS 增加+0.32±0.26μm)。同样的矫正也可以通过眼屈光折射的变化和角膜曲率读数的变化来确定。
SmartSight 角膜透镜取出术后前 3 个月是安全有效的,术后结果表明视力有所改善。